Improved OutcomesTreatment Imperial patients among first in world to receive pioneering gene-editing treatment for high cholesterol

Published on 2nd June 2026
Improved OutcomesTreatment Imperial patients among first in world to receive pioneering gene-editing treatment for high cholesterol

A researcher at Imperial College London contributed to an international trial of a pioneering gene-editing treatment that could transform care for people living with inherited high cholesterol and heart disease.

Read the full story on Imperial News

More stories from Metabolic & Endocrine

Prevention DNA-informed diet could help lower health risks linked to high blood sugar

Prevention DNA-informed diet could help lower health risks linked to high blood sugar

Published on 7th March 2024
Prevention Type 2 diabetes can be predicted 10 years ahead using AI

Prevention Type 2 diabetes can be predicted 10 years ahead using AI

Published on 18th November 2024
EDIPrevention Rising childhood obesity from pandemic could cost UK billions

EDIPrevention Rising childhood obesity from pandemic could cost UK billions

Published on 25th January 2024
Treatment Topical HRT protects bone density in women whose periods stop due to anorexia or intense exercise

Treatment Topical HRT protects bone density in women whose periods stop due to anorexia or intense exercise

Published on 16th February 2026
Treatment IVF treatment success could be augmented with AI

Treatment IVF treatment success could be augmented with AI

Published on 8th January 2025